INFINITY PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Infinity Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 3, 2023 was 90.8M shares, a 1.66% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 90.8M +1.48M +1.66% Aug 3, 2023 10-Q 2023-08-10
Q1 2023 89.4M +267K +0.3% Mar 21, 2023 10-K 2023-03-28
Q3 2022 89.3M +330K +0.37% Nov 7, 2022 10-Q 2022-11-14
Q2 2022 89.3M +558K +0.63% Aug 2, 2022 10-Q 2022-08-09
Q1 2022 89.2M +516K +0.58% Mar 25, 2022 10-K 2022-03-29
Q3 2021 89M +24.8M +38.6% Oct 26, 2021 10-Q 2021-11-02
Q2 2021 88.7M +29.8M +50.7% Jul 20, 2021 10-Q 2021-07-27
Q1 2021 88.6M +31.2M +54.3% Mar 5, 2021 10-K 2021-03-16
Q3 2020 64.2M +7.18M +12.6% Nov 3, 2020 10-Q 2020-11-09
Q2 2020 58.9M +1.84M +3.23% Jul 23, 2020 10-Q 2020-07-30
Q1 2020 57.4M +508K +0.89% May 6, 2020 10-Q 2020-05-11
Q3 2019 57M +162K +0.29% Oct 21, 2019 10-Q 2019-10-30
Q2 2019 57M +176K +0.31% Jul 23, 2019 10-Q 2019-07-30
Q1 2019 56.9M +4.96M +9.55% Mar 8, 2019 10-K 2019-03-14
Q3 2018 56.9M +6.16M +12.1% Oct 31, 2018 10-Q 2018-11-05
Q2 2018 56.9M +6.16M +12.2% Aug 1, 2018 10-Q 2018-08-07
Q1 2018 52M +1.52M +3.01% Mar 1, 2018 10-K 2018-03-15
Q3 2017 50.7M +982K +1.97% Nov 2, 2017 10-Q 2017-11-07
Q2 2017 50.7M +1.1M +2.22% Jul 28, 2017 10-Q 2017-08-03
Q1 2017 50.4M +996K +2.01% Apr 28, 2017 10-Q 2017-05-09
Q3 2016 49.7M +499K +1.01% Oct 31, 2016 10-Q 2016-11-09
Q2 2016 49.6M +400K +0.81% Jul 29, 2016 10-Q 2016-08-09
Q1 2016 49.4M +405K +0.83% Apr 29, 2016 10-Q 2016-05-04
Q3 2015 49.2M +464K +0.95% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 49.2M +602K +1.24% Jul 31, 2015 10-Q 2015-08-06
Q1 2015 49M +500K +1.03% Apr 30, 2015 10-Q 2015-05-06
Q3 2014 48.8M +680K +1.42% Nov 3, 2014 10-Q 2014-11-10
Q2 2014 48.6M +603K +1.26% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 48.5M +714K +1.49% Apr 21, 2014 10-Q 2014-05-06
Q4 2013 48.3M Feb 14, 2014 10-K 2014-02-25
Q3 2013 48.1M +8.61M +21.8% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 48M +20.7M +76% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 47.8M +20.9M +77.9% Mar 31, 2013 10-Q 2013-05-07
Q3 2012 39.5M +12.8M +48% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 27.3M +667K +2.51% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 26.9M Mar 31, 2012 10-Q 2012-05-08
Q3 2011 26.7M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 26.6M Jun 30, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.